Press release
Robust Venture Capital Investments Fuel Biopharmaceutical Cmo Market Growth Driving Market Acceleration in the Biopharmaceutical CMO Industry, 2025
Biopharmaceutical CMO
How Large Will the Biopharmaceutical CMO Market Size By 2025?
The size of the biopharmaceutical CMO market has been expanding swiftly in the previous years. It's projected to proliferate from $24.81 billion in 2024 to about $28.09 billion in 2025, clocking a compound annual growth rate (CAGR) of 13.2%. Factors such as heightened demand for biopharmaceuticals, globalization trends, escalating TH*Care spending, regulatory backing, and a surge in research funding are credited for the growth registered in the historical period.
How Big Is the Biopharmaceutical CMO Market Size Expected to Grow by 2029?
Over the coming years, the biopharmaceutical CMO market is projected to experience swift expansion, culminating in a value of $48.04 billion by 2029, having grown at a compound annual growth rate (CAGR) of 14.4%. The surge during the prediction period is linked to factors such as the proliferation of telehealth and remote trials, worldwide health programs, and an increase in disposable income. Leading trends anticipated during this period encompass dominance by advanced therapies, industry 4.0 and digitalization, continuous production, and the adoption of green and sustainable practices.
View the full report here:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report
Which Key Market Drivers Powering Biopharmaceutical CMO Market Expansion and Growth?
The escalating number of older adults is predicted to boost the biopharmaceutical CMO market's expansion. Individuals aged 60 and above are at a heightened risk of experiencing a heart attack, stroke, or developing coronary heart disease and heart failure, compared to their younger counterparts. This rise in the older population is fueled by progress in TH*Care, dwindling birth rates, and the maturing baby boomer generation. Its increase is catalyzing the demand for biopharmaceutical treatments aimed at treating age-associated issues, such as cardiovascular disorders. Biopharmaceutical CMOs are crucial in this regard as they offer specialized manufacturing abilities for intricate biologics and personalized medicines designed to meet these requirements. For instance, data from the Population Reference Bureau, a non-profit organization based in the US, projected in January 2024 that the count of Americans 65 years old and above is anticipated to surge from 58 million in 2022 to 82 million by 2050. Hence, the rise in the older population is promoting the growth of the biopharmaceutical CMO market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Biopharmaceutical CMO Market?
The rise of technology is a noteworthy trend becoming increasingly prevalent in the biopharmaceutical CMO market. Predominant companies in this industry are making significant progress in novel technologies and futuristic research, incorporating the Internet of Things (IoT). IoT involves the use of interconnected sensors and actuators to regulate and monitor the environment, objects in motion within it, and human activity. They can generate a large volume of data meticulously gathered from sensors, actuators, and other related components embedded in manufacturing devices and networked computer systems. This data can be analyzed to uncover new insights and opportunities to boost production efficiency, automate surveillance and regulation tasks, and create adaptable manufacturing systems. For example, in February 2022, Korean bio-cold chain technology company, M2Cloud, collaborated with French IoT communication specialist Thales, to develop an IoT-based LTE monitoring system specifically for biopharmaceutical monitoring. This system assists in real-time tracking of freezers, refrigerated warehouses, and other essential delivery boxes. By simply turning on the power, it can remotely validate temperature and location data in real-time. The integration of these technologies developed for biopharmaceutical oversight enhances the safety of pharmaceutical products.
What Are the Emerging Segments in the Biopharmaceutical CMO Market?
The biopharmaceutical cmo market covered in this report is segmented -
1) By Product: Biologics, Biosimilars
2) By Source: Mammalian, Non-Mammalian
3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging
Subsegments:
1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell and Gene Therapies
2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7771&type=smp
Who Are the Global Leaders in the Biopharmaceutical CMO Market?
Major companies operating in the biopharmaceutical cmo market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG
Which are the Top Profitable Regional Markets for the Biopharmaceutical CMO Industry?
North America was the largest region in the biopharmaceutical CMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7771
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Robust Venture Capital Investments Fuel Biopharmaceutical Cmo Market Growth Driving Market Acceleration in the Biopharmaceutical CMO Industry, 2025 here
News-ID: 4075531 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for CMO
Healthcare Cmo Market Size Analysis by Application, Type, and Region: Forecast t …
USA, New Jersey- According to Market Research Intellect, the global Healthcare Cmo market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The healthcare contract manufacturing organization (CMO) market is witnessing steady expansion due to increasing demand for outsourced pharmaceutical and medical device production. Rising healthcare costs…
New Fractional CMO Agency Offers Fractional CMO Services to Businesses of All Si …
Modern CMO, a new fractional CMO agency, has officially launched to offer businesses of all sizes access to expert-level marketing strategies and a team of experienced CMOs to lead their marketing initiatives.
Modern CMO's fractional CMO services provide businesses with access to the same level of expertise as a full-time CMO, without the costly overhead expenses. This means that businesses can tap into Modern CMO's pool of highly skilled marketing professionals…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
